383 related articles for article (PubMed ID: 29298899)
1. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts.
Edin ML; Gruzdev A; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Fleming I; Zeldin DC
J Biol Chem; 2023 Apr; 299(4):103049. PubMed ID: 36822325
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
4. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
5. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC
Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962
[TBL] [Abstract][Full Text] [Related]
6. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.
Strauss KI; Gruzdev A; Zeldin DC
Prostaglandins Other Lipid Mediat; 2013; 104-105():18-24. PubMed ID: 22922090
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
9. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
[TBL] [Abstract][Full Text] [Related]
10. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
11. Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase.
Luria A; Morisseau C; Tsai HJ; Yang J; Inceoglu B; De Taeye B; Watkins SM; Wiest MM; German JB; Hammock BD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E375-83. PubMed ID: 19458064
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
13. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
15. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
16. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
17. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid cytochrome P450 epoxygenase pathway.
Spector AA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function.
Edin ML; Gruzdev A; Bradbury JA; Graves JP; Muse GW; Goulding DR; Lih FB; DeGraff LM; Zeldin DC
Biochem Pharmacol; 2024 Apr; ():116237. PubMed ID: 38679211
[TBL] [Abstract][Full Text] [Related]
20. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
Deng Y; Edin ML; Theken KN; Schuck RN; Flake GP; Kannon MA; DeGraff LM; Lih FB; Foley J; Bradbury JA; Graves JP; Tomer KB; Falck JR; Zeldin DC; Lee CR
FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]